Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
enfortumab vedotin
×
Clear all
Filters
2
NCT06483334
2026-02-18
MK-3475-04C
Merck Sharp & Dohme LLC
Phase 1/2
Active not recruiting
38 enrolled
NCT04700124
2026-02-05
KEYNOTE-B15
Merck Sharp & Dohme LLC
Phase 3
Completed
808 enrolled